Senior insider sale
Chief Financial Officer at ACUMEN PHARMACEUTICALS, INC. — senior position signals high conviction
$49.6K
25.95K shares
ZUGA MATT plans to sell 25.95K shares of ACUMEN PHARMACEUTICALS, INC. valued at approximately $49.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.69K | — |
| Total | 1.69K | ||
Completed
Units to sell
2.47K
Market value
$4.5K
Units to sell
6.89K
Market value
$12.5K
Units to sell
5.80K
Market value
$11.6K
Units to sell
5.10K
Market value
$10.0K
Units to sell
4K
Market value
$7.8K
Planned — Approximate Date
Units to sell
1.69K
Market value
$3.1K
Units
25.95K
Value
$49.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/21/2026 | 2.47K | $4.5K | — | Completed |
1/8/2026 | 6.89K | $12.5K | — | Completed |
1/7/2026 | 5.80K | $11.6K | — | Completed |
1/6/2026 | 5.10K | $10.0K | — | Completed |
1/5/2026 | 4K | $7.8K | — | Completed |
| Planned — Approximate Date | ||||
1/22/2026 | 1.69K | $3.1K | NASDAQ | Planned |
| Total | 25.95K | $49.6K | ||